Tweaking Samples for High-Speed Chemistry

Tweaking Samples for High-Speed Chemistry

A nanoprinting technique can be used to modify millions of samples.

A new way to print, and modify, nanoscale molecular samples could mean faster drug discovery and scientific experimentation. Combinatorial chemistryexposing a huge array of slightly different molecules to samples in parallelis an extremely fast way to screen drug molecules, or to test the way certain molecules affect biological cells.

Researchers at the International Institute for Nanotechnology at Northwestern University, in Chicago, led by director Chad Mirkin, have devised a way to rapidly prepare the smallest type of combinatorial chemistry array. They tested the approach by exposing stem cells to different-sized samples of fibronectin, a protein that plays an important role in cell adhesion, growth, and differentiation. The researchers used a nanoprinting technique previously developed by Mirkin's group, called polymer pen lithography, that delivers samples to a substrate in parallel via the tips of millions of pyramid-shaped "pens."

The innovation was to tilt the array slightly as these molecules were deposited, so that the pyramids closest to the surface make more contact and leave more material, while those farthest away leave less. Mirkin and colleagues found that, by tilting an array just 0.01 degrees, they could create 25 million fibronectin deposits of different size and structure.

When they applied stem cells to the array, they found that the size of the fibronectin molecules controlled the differentiation of these cells. "In the experiment, we only adjusted the size," says Mirkin, whose group published their results in Proceedings of the National Academy of Science earlier this month

It may eventually be possible to change other features of samples, such as composition or shape, using the same technique. These are common features explored by drug companies, Mirkin says.

"The technique they developed is extremely powerful with the generation of a large number of features in parallel," says Bing Yan, director of the High-Throughput Analytical Chemistry Facility at St Jude's Children's Research Hospital in Memphis, Tennessee, who was not involved with the research. "The number alone is very impressive."

Along with drug testing, Yan says the approach could be used to test the reactivity of catalysts and the properties of new materials.

See the original post here:
Tweaking Samples for High-Speed Chemistry

HepatoChem to Present at Early-Stage Life Sciences Technology Conference VIII

MAHWAH, N.J., March 23, 2012 /PRNewswire/ -- HepatoChem, Inc, a chemistry-based technology platform company with a primary focus on metabolite production from bioactive small molecules, and an investment holding of Heartland Bridge Capital, Inc. (OTCBB: HLBC.OB - News), announced that it will present at the Early-Stage Life Sciences Technology Conference VIII at the Merck Research Laboratories in Boston, MA, on April 12, 2012.

The Early-Stage Life Sciences Technology Conference will showcase 20 life sciences technologies developed at the universities, research institutions, and hospitals of Massachusetts and recently formed Massachusetts companies to an audience of angel investors, venture capitalists and corporate investors. http://www.mattcenter.org/lsconf2012/

HepatoChem recently moved to its new laboratory in Beverly, MA. This is an important step for HepatoChem, which is committed to offering unique metabolite production services. This laboratory is part of the NorthShore Biotech Innoventure.

About HepatoChem, Inc

HepatoChem is a chemistry-based technology platform company with a primary focus on metabolite production from bioactive small molecules. Founded by Marc Bazin, previously with Pfizer, Inc., and Prof. John T. Groves, the Hugh Stott Taylor Chair of Chemistry at Princeton University, HepatoChem is dedicated to developing technologies that help pharmaceutical companies improve the quality of drug development pipelines. HepatoChem offers a unique and powerful solution to resolve the traditional lack of rapid and efficient metabolite access in drug discovery. http://www.hepatochem.com

About Heartland Bridge Capital, Inc.

Heartland Bridge Capital, Inc. (OTCBB:HLBC.OB - News) is a public company that, in addition to managing its own operating entities, participates in emerging companies run by exceptionally talented entrepreneurs and operating executives who are dedicated to creating positive change in our world. HLBC functions as an owner, product developer, and investor focused primarily on providing equity, acquisition debt, or bridge financing to emerging high-growth companies and entrepreneurs in the areas of clean energy, waste management, and life sciences. http://www.heartlandbridgecapital.com.

To request an investor packet, or to receive updates on Heartland Bridge Capital register online at http://www.wallstreetnewscast.com/request/hlbc.html

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Heartland Bridge Capital, Inc. cautions that statements made in this news release relating to the investment in HepatoChem, and potential investment in and the business direction of the Company, constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates, and assumptions made by management. Actual results could differ materially from current projections or implied results. Heartland Bridge Capital, Inc. undertakes no obligation to revise these statements following the date of this news release.

Read this article:
HepatoChem to Present at Early-Stage Life Sciences Technology Conference VIII

Europe Clinical Chemistry & Immunodiagnostics Markets Discussed in New Report Published at MarketPublishers.com

LONDON--(BUSINESS WIRE)--

Due to a number of factors like new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; as well as intensifying competition, the clinical chemistry and immunodiagnostics markets are undergoing significant changes. Some segments, such as routine chemistry, start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. All these upcoming transformations in the marketplace are expected to provide amazing opportunities for a variety of new instruments and reagent systems, as well as auxiliary products, like specimen preparation devices, controls, calibrators.

New research report The 2012 European Clinical Chemistry and Immunodiagnostics Markets: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies developed by Venture Planning Group (VPG) explores future marketing and technological trends in five major Europeancountries (France, Germany, Italy, Spain and the UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles top market players; and identifies specific product and marketing opportunities facing suppliers during the next five years.

Companies mentioned in the report include: Abbott Laboratories, AdnaGen, Ambrilia, AMDL, Beckman Coulter, Biomedical Diagnostics, BioMerieux, Bio-Rad, Canag Diagnostics, Dako, DiaSorin, Eiken, Fujirebio, Instrumentation Laboratory, J&J, Kyowa Medex, Matritech, Roche, Siemens, Sysmex, Thermo Fisher, Trinity Biotech, Tosoh, Wako, and Wallac.

Report Details:

Title: The 2012 European Clinical Chemistry and Immunodiagnostics Markets: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies Published: March, 2012 Pages: 900 Price: US$ 18,500

http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/2012_european_clinical_chemistry_n_immunodiagnostics_markets_france_germany_italy_spain_uk_emerging_opportunities_n_business_expansion_strategies.html

Report Contents:

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW A. Major Routine Chemistry Tests 1. Albumin 2. Alkaline Phosphatase 3. ALT/SGPT 4. Ammonia 5. Amylase 6. AST/SGOT 7. Bilirubin 8. Blood Gases 9. Blood Urea Nitrogen (BUN) 10. Calcium 11. Cholesterol 12. Cholinesterase 13. Creatinine 14. Electrolytes a. Carbon Dioxide/Bicarbonate b. Chloride c. Potassium d. Sodium 15. Fructosamine 16. Gamma-Glutamyl Transpeptidase (GGT) 17. Glucose 18. High Density Lipoprotein (HDL) 19. Iron 20. Lactate Dehydrogenase (LDH) 21. Magnesium 22. Phosphorus 23. Protein 24. Triglycerides

Read the original here:
Europe Clinical Chemistry & Immunodiagnostics Markets Discussed in New Report Published at MarketPublishers.com

Research and Markets: Metal Chemistry of Porphyrinoids

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/67961fb7/metal_chemistry_of) has announced the addition of John Wiley and Sons Ltd's new book "Metal Chemistry of Porphyrinoids" to their offering.

The examination of porphyrins and phthalocyanines and their metal complexes remains a pillar of the chemical sciences spanning fundamental chemistry and applications to biological chemistry and design of advanced materials. While the chemistry of the metalloporphyrins and metallophthalocyanines has been extensively explored, the metal chemistry of many of the analogs and isomers of the porphyrin macrocycle has only recently matured into a significant field.

With recent significant advances in the organic chemistry of aromatic polypyrrolic macrocycles, leading to the easy availability of porphyrin analogs and isomers, research into the metal chemistry of these compounds is allowing a deeper understanding of their role in biochemistry and the development of new molecules with exciting applications in medicine, catalysis, materials science, and sensors.

Metal Chemistry of Porphyrinoids summarizes these recent synthetic developments, particularly in respect of metallation strategies for freebase porphyrinoids, as well as progress towards applications in areas such as sensor and optical materials, catalysis and medicine. This reference summarizes those developments as well as progress towards a variety of applications which mirror the many uses of normal porphyrins and phthalocyanines.

Key Topics Covered:

- Chapter 1 Introduction

- Chapter 2 Metallation strategies for the porphryinoids

- Chapter 3 Isomeric porphyrins

- Chapter 4 Ring modified porphyrins

Read more from the original source:
Research and Markets: Metal Chemistry of Porphyrinoids

Research and Markets: Supramolecular Polymer Chemistry

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/b81e8458/supramolecular_pol) has announced the addition of John Wiley and Sons Ltd's new book "Supramolecular Polymer Chemistry" to their offering.

Presenting the work of pioneering experts in this exciting field of supramolecular polymer chemistry, this monograph covers an extensive range of applications, including drug delivery and catalysis. It focuses on new structures and phenomena of cyclodextrin-based supramolecular polymers and many other compound classes. While providing a deeper insight in macromolecular recognition and the mechanisms of living systems, this book also introduces fascinating novel phenomena beyond natural systems.

Key Topics Covered:

- Multiple Hydrogen-Bonded Supramolecular Polymers

- Cyclodextrin-Based Supramolecular Polymers

- Supra-Macromolecular Chemistry: Toward Design of New Organic Materials from Supramolecular Standpoints

- Polymerization with Ditopic Cavitand Monomers

- Polymers Containing Covalently Bonded and Supramolecularly Attached Cyclodextrins as Side Groups

- Antibody Dendrimers and DNA Catenanes

Read the original post:
Research and Markets: Supramolecular Polymer Chemistry

Old storyline, new chemistry and comedy in 'Bent'

LOS ANGELES -- It's a tale as old as time: A tough, type A lawyer hires a surfer-dude contractor to remodel her kitchen. OK, the type A lawyer and surfer-dude characters aren't that classic, but the story of two very different people finding a connection has been around forever.

NBC is banking that a new spin on this old plot will create enough sparks to make the new comedy "Bent" a hit. It will be up to Amanda Peet, the lawyer, and David Walton, the surfer, to generate those sparks.

"I think chemistry, in real life, it's hard to put words around it. You either have it with someone or you don't," Walton says. He thinks viewers will see -- and be attracted to -- the chemistry between he and Peet.

Both actors credit executive producer Tad Quill with writing a script that has enough sexual tension and sexual suspense to make it easy to create the needed sexual electricity.

"It's not something that I think about or that I set out to accomplish. It's just play the scene," Peet says of the connection she has to her co-star.

She has played those kind of scenes in TV and film projects before, from "Studio 60 on the Sunset Strip" to "The Whole Nine Yards." The key to making the audience believe there is some type of connection is believable casting.

Peet and Quill knew immediately Walton was the guy for "Bent."

"When Tad and I were looking for a co-star, we definitely wanted to find something that would make the show really sexy. We wanted to create a real kind of lifestyle rift between these two people. And when David Walton came in, it was obvious that he was our guy. And, frankly, from the bottom of my heart, I am shocked that I get to be with him and not Reese Witherspoon or Jennifer Lopez or some movie star right now because he's just a really crazy genius combination of being really funny and really gorgeous and kind of a dork," Peet says. "I feel very lucky that we found him."

Walton is a veteran of situation comedies, having starred in "Perfect Couples," "100 Questions" and "Cracking Up."

Quill, who worked as a producer on "Scrubs," "Spin City," "Good Morning, Miami" and "Samantha Who?," wants "Bent" to have the same romantic comedy elements of those shows while being just a little different.

View post:
Old storyline, new chemistry and comedy in 'Bent'

Proctor chemistry students participate in March Madness

Studentsin Mary Ann Mazzolas chemistry class at Proctor High School in Utica are among 10,000 high school students in the United States who are experiencing their own March Madness as they participate in local Chemistry Olympiad competitions the first step toward securing a spot on the U.S. Chemistry Olympiad team.

Later this summer, the team will go up against chemistry students from 70 other nations at the 44th International Chemistry Olympiad outside Washington, D.C.

Next month, Mazzolas top two chemistry students will go on to take the U.S. National Chemistry Olympiad national exam with the top two students from all other participating high schools in the country.

Selection for the national exam is based on scores in the local competition and teacher recommendations. The top 20 students from the national competition are then invited to a two-week intensive study camp held in June at the U.S. Air Force Academy in Colorado Springs.

At the camps conclusion, the final four students are chosen to represent the United States at the International Chemistry Olympiad, where they compete with the worlds most talented high school students for gold, silver and bronze medals.

The local examinations consist of 60 multiple-choice questions representing a fairly wide range of difficulty, usually completed in 110 minutes. The three-part, 4.5-hour national exam includes multiple-choice questions, problem solving and a lab.

Read more:
Proctor chemistry students participate in March Madness

Chemistry sets 'Bent' afire

LOS ANGELES -- As executive producer of the new NBC comedy"Bent," Tad Quill is responsible for everything from writing the first episode to making sure the caterer doesn't poison anyone. But his most important role may be the most underappreciated one: playing matchmaker.

Good sitcoms -- and this is one of them -- need snappy dialogue, a compelling premise and engaging characters. But the most critical ingredient is chemistry between the lead actors, especially when the story hinges on a will-they-or-won't-they relationship.

Amanda Peet plays Alex, a recent divorcee who hires a gambling addict, Pete (David Walton), to remodel her house. You've seen this setup before -- she's cautious, he's wild; she's responsible, he's unreliable -- but it more than holds up because the two banter like a modern-day Cary Grant and Rosalind Russell.

You're 99.9 percent sure they'll end up in each other's arms, but watching them do the long, slow dance to get there is still a treat.

Peet, who was attached to the project from the start, read with about 20 actors and Quill saw more than 50 guys before casting Walton, who starred in the short-lived sitcoms"Perfect Couples"and "100 Questions."

"You know when it's right instantaneously," Quill says. "It's one thing to have actors saying a joke that's kind of funny, but when two people who really know what they're doing come together, you can be laughing out loud."

Walton isn't sure what makes this partnership work so well.

"Chemistry, like in real life, is hard to put words around," he says.

It helps to work with Peet, who has previously sizzled with Bruce Willis and John Cusack. She specializes in tough, intelligent characters who slowly reveal their vulnerabilities, fears and a desperate need for something more intimate than a handshake.

"It's not something I think about or set out to accomplish," Peet, whose last series, Aaron Sorkin's "Live From the Sunset Strip," also called for romantic electricity, says. "Tad's script has a lot of sexual tension and sexual suspense. You just play that."

Read more:
Chemistry sets 'Bent' afire

CHEMGEN Pharma International, a Dr. Kali Pradip Chaudhuri Company, Appoints Dr. Debasis Das as General Manager of …

KOLKATA, India--(BUSINESS WIRE)--

CHEMGEN Pharma International, solely owned by Dr. Kali Pradip Chaudhuri, a Contract Research Organization serving the global pharmaceutical and biotechnology companies with innovative chemistry expertise, announced the appointment of Dr. Debasis Das as the company's General Manager of Business Development. Dr. Das will be heading the business development department with focus on driving economic growth including acceleration of sales and marketing initiatives to expand the company's footprint in the global market.

With extensive experience in both the pharmaceutical industry and academia, Dr. Das brings to Chemgen Pharma expertise in the fields of medicinal chemistry, synthetic organic chemistry, custom synthesis and custom manufacturing. Dr. Das' knowledge gained from supporting a wide range of projects around the world and his overall capabilities to help create innovative solutions to meet customers' expectations will be a great asset to Chemgen Pharma.

Before joining Chemgen Pharma, Dr. Das returned to India from Shanghai after his four years of service at Wuxi AppTec Co. Ltd. where he served as Associate Director in the medicinal chemistry department. Prior to WuXi, Dr. Das held various positions in contract research organizations and pharmaceutical companies in India including Dr. Reddys Research Foundation, Chembiotek Research International and Jubilant Chemsys. His impressive experience includes management, mentoring and training a large number of Ph.D. and M.Sc. scientists and chemists, overseeing research and development, managing integrated drug discovery and collaboration projects with partners from the USA and Europe.

Dr. Das holds a Ph.D. in synthetic organic chemistry from Jadavpur University and was engaged in a post doctoral research at Duke University with international publications. Dr. Das is also involved with the University colleges as a guest faculty and teaching postgraduate students on the topics of Bioactive organic compounds, Antibiotics and Aromaticity.

About CHEMGEN Pharma International

CHEMGEN Pharma International is a Contract Research Organization serving the global pharmaceutical and biotechnology companies with innovative chemistry expertise, reliable and flexible resources. Since its inception in 2004, Chemgen Pharma has built a state-of-the-art infrastructure with highly experienced and committed team members to deliver superior quality services and competitive pricing to its customers worldwide - enabling them to operate efficiently and profitably.

See the original post here:
CHEMGEN Pharma International, a Dr. Kali Pradip Chaudhuri Company, Appoints Dr. Debasis Das as General Manager of ...

Guest Post: Apple Succumbs To Battery Chemistry?

Submitted by Sabregold1999

Apple Succumbs To Battery Chemistry

In light of the news that Apple is issuing a dividend with the stock flirting with all-time highs, it might be a good time to assess where Apple is with its two products, the Iphone and the Ipad. There is no arguing with the success of these products, but that is not the real story that needs addressing. The real story for Apple is battery chemistry and much like the automakers it fails.

Apple, like a lot of gadget makers needs new iterations to generate a buzz. If the newest product lacks significant improvements the growth model suffers. For Apple any and all great innovations on the hardware side will be limited, simply because battery chemistry, unlike Moores law, moves at a snails pace. Here is some evidence to show you the proof.

Lets examine the latest offering from the IPad3. Apple was able to increase the size of the battery in its device by about 70%. It did this by engineering a more efficient internal set-up. It did NOT increase the energy density of the individual lithium ion cells. Why was all of this done? They did it for two reasons.

4G eats batteries and that new screen hogs power. So, without engineering a better set-up, the IPad 3 would have been much larger, instead of only slightly larger.

Why is this important? If you examine a laptop, theres a reason why the battery is as large as it is relative to the device. The laptop uses significant power and lithium ion batteries are only capable of packing so much energy density into a defined space. Design engineers at Apple and Samsung know perfectly well, that asking your phone or tablet to replace that of your laptop comes with one big problem that no one has solved; namely, battery chemistry.

For a company like Apple, it truly is constrained on what it can do moving forward with the Ipad and the Iphone franchises. Computing power comes at a price in small packages and with the latest revelation that energy densities did not improve, an investor might conclude that the next iterations will have to contain extraordinary software rather than hardware developments.

Oh and it is for this reason that this author believes Apple is tackling the TV market next. Stay tuned.

Your rating: None Average: 5 (10 votes)

Read more from the original source:
Guest Post: Apple Succumbs To Battery Chemistry?

MIT's Prof. Klavs Jensen Wins IUPAC-ThalesNano International Prize for Outstanding Work in Flow Chemistry

RESEARCH TRIANGLE PARK, NC and BUDAPEST, HUNGARY and BOSTON, MA--(Marketwire -03/20/12)- IUPAC and ThalesNano have announced at the 2nd International Conference of the Flow Chemistry Society in Munich that the International Flow Chemistry Prize was awarded to Prof. Klavs Jensen, Warren K Lewis Professor and Department Head, Department of Chemical Engineering at MIT. The prize was awarded in recognition of Prof. Jensen's extensive activities and publications, which have made an outstanding contribution to the field of flow chemistry both in academia and industry.

During his acceptance speech, Prof. Jensen said: "Dr. Ferenc Darvas, thank you for this tremendous honor and for your leadership of the Flow Chemistry field. Also thank you to Prof. Droescher for supervising this special IUPAC prize. I would also like to thank my many colleagues in the flow chemistry and microreactor communities, my colleagues at MIT (Prof. Bawendi, Buchwald, and Jamison), and importantly, my students and postdocs. I have learnt a lot from everyone!"

Dr. Ferenc Darvas, President and Chairman of ThalesNano Inc., commented: "It's a great honor for both ThalesNano and myself personally to be able to present this award to Prof. Jensen in recognition of such a talented scientist and contributor to the field flow of chemistry. It is my hope that this award will turn the face of the chemistry community in 2012 towards this interesting and elegant synthetic technique."

Dr. Michael Droescher, Chairman of the IUPAC Committee on Chemistry and Industry, added: "Congratulations to Prof. Jensen on this award. The dramatic impact of flow chemistry in recent years and decades deserves an acknowledgement from the IUPAC. As a respect for all the chemists' work in this field, we are delighted to contribute to this prize hoping it will bring more attention towards such a valuable technique."

About ThalesNano, Inc.:

ThalesNano is a world-leading provider of continuous process chemistry instruments in the rapidly developing market of laboratory and process scale flow reactors. The company has the widest portfolio of bench-top continuous process instruments. Its R&D 100 award winning H-Cube continuous-flow hydrogenation reactor is used in hundreds of laboratories and has become the new industry standard for hydrogenation. http://www.thalesnano.com

About IUPAC:

IUPAC was formed in 1919 by chemists from industry and academia. For over eight decades, the Union has succeeded in fostering worldwide communications in the chemical sciences and in uniting academic, industrial and public sector chemistry in a common language. Recently, IUPAC has been pro-active in establishing a wide range of conferences and projects designed to promote and stimulate modern developments in chemistry.

About the Flow Chemistry Society:

The Flow Chemistry Society was formed by internationally recognized flow chemistry experts in 2010 to unite and represent those who are actively working on this rapidly developing field. The Society is dedicated to enhancing the public appreciation of flow chemistry and its integration into everyday practice throughout the world by delivering the latest knowledge and making it available for the entire chemistry community.

See the original post:
MIT's Prof. Klavs Jensen Wins IUPAC-ThalesNano International Prize for Outstanding Work in Flow Chemistry

Cosmic rays modify chemistry of lunar ice

Washington, Mar 20 (ANI): Cosmic rays bombarding moon fundamentally change chemistry and colour of the lunar ice and dirt, a new study has revealed.

Space scientists from the University of New Hampshire and multi-institutional colleagues report they have quantified levels of radiation on the moon's surface from galactic cosmic ray (GCR) bombardment that over time causes chemical changes in water ice and can create complex carbon chains similar to those that help form the foundations of biological structures.

In addition, the radiation process causes the lunar soil, or regolith, to darken over time, which is important in understanding the geologic history of the moon.

The paper is based on measurements made by the CRaTER instrument onboard NASA's Lunar Reconnaissance Orbiter (LRO) mission.

The telescope provides the fundamental measurements needed to test our understanding of the lunar radiation environment and shows that 'space weathering' of the lunar surface by energetic radiation is an important agent for chemical alteration.

CRaTER measures material interactions of GCRs and solar energetic particles (SEPs), both of which present formidable hazards for human exploration and spacecraft operations.

CRaTER characterizes the global lunar radiation environment and its biological impacts by measuring radiation behind a 'human tissue-equivalent' plastic.

Serendipitously, the LRO mission made measurements during a period when GCR fluxes remained at the highest levels ever observed in the space age due to the sun's abnormally extended quiet cycle.

During this quiescent period, the diminished power, pressure, flux and magnetic flux of the solar wind allowed GCRs and SEPs to more readily interact with objects they encountered - particularly bodies such as our moon, which has no atmosphere to shield the blow.

"This has provided us with a unique opportunity because we've never made these types of measurements before over an extended period of time, which means we've never been able to validate our models," said paper's lead author Nathan Schwadron, an associate professor of physics at the UNH Space Science Center within the Institute for the Study of Earth, Oceans, and Space (EOS).

Read the rest here:
Cosmic rays modify chemistry of lunar ice

NBA High-5: Grizzlies flirt with chemistry experiment by courting Gilbert Arenas

The five most interesting stories, rumors and notes in the NBA: 1. Chemistry test: Paging Lionel Hollins. Professor Hollins, please report to the chemistry lab.

The Memphis Grizzlies are having a very nice season, overcoming the loss of forward Zach Randolph to put themselves in position to finish with a upper-division Western Conference playoff seed. At 25-18, they are a half game behind the Clippers for the No. 4 spot.

On Friday, Randolph returned after missing 37 games with a knee injury. In two games since returning, Randolph is averaging 14 points and nine rebounds in 24.5 minutes off the bench.

But do the Grizzlies need one more piece? Apparently they think so, and on Monday, they brought in veteran guard Gilbert Arenas for a physical and will sign him if he passes, the Commercial Appeal's Ronald Tillery reports.

This should be interesting. Arenas, 30, has played 10 NBA seasons. During three of them -- 2004-05, '05-06 and '06-07 -- he was among the league's best offensive players, averaging 25.5, 29.3 and 28.4 points.

But knee injuries and off-court issues -- especially his conviction on a gun charge and subsequent suspension in 2010 -- changed things. Before this season, Orlando -- which obtained him via a trade last season -- waived him under the league's amnesty clause.

Arenas is one of six players who were amnestied this season, and none have bounced back to really make their old teams regret it. If Arenas plays, he would be one of three amnestied players currently active in the NBA, joining the Kings' Travis Outlaw (waived by Nets) and Knicks' Baron Davis (waived by Cavaliers).

The Clippers' Chauncey Billups (waived by Knicks) is out for the season with a torn Achilles' tendon, Charlie Bell (waived by Warriors) is playing in Italy, and, as we all know, Brandon Roy has retired.

If the record of amnestied players hints that Arenas won't be an All-Star for Memphis, can he be an effective backup point guard, as Davis has become for the Knicks? That's the role the Grizzlies need filled -- a backup behind established starter Mike Conley. They don't necessarily need a gunner off the bench, a role filled by O.J. Mayo, who ranks third on the team in shot attempts.

The signing of Arenas shows that the Grizzlies are looking to contend now, and there might be a good reason. There are rumblings in Memphis about a possible ownership change. Larry Ellison, the CEO of Oracle who was a finalist to buy the Golden State Warriors and also made an attempt to buy the New Orleans Hornets, is apparently making a run at the Grizzlies.

See the original post:
NBA High-5: Grizzlies flirt with chemistry experiment by courting Gilbert Arenas

Cosmic Rays Alter Chemistry of Lunar Ice

Space scientists from the University of New Hampshire and multi-institutional colleagues report they have quantified levels of radiation on the Moon's surface from galactic cosmic ray (GCR) bombardment that over time causes chemical changes in water ice and can create complex carbon chains similar to those that help form the foundations of biological structures. In addition, the radiation process causes the lunar soil, or regolith, to darken over time, which is important in understanding the geologic history of the Moon.

The scientists present their findings in a paper published online in the American Geophysical Union's Journal of Geophysical Research (JGR). The paper, titled "Lunar Radiation Environment and Space Weathering from the Cosmic Ray Telescope for the Effects of Radiation (CRaTER)," is based on measurements made by the CRaTER instrument onboard NASA's Lunar Reconnaissance Orbiter (LRO) mission. The paper's lead author is Nathan Schwadron, an associate professor of physics at the UNH Space Science Center within the Institute for the Study of Earth, Oceans, and Space (EOS). Co-author Harlan Spence is the director of EOS and lead scientist for the CRaTER instrument.

The telescope provides the fundamental measurements needed to test our understanding of the lunar radiation environment and shows that "space weathering" of the lunar surface by energetic radiation is an important agent for chemical alteration. CRaTER measures material interactions of GCRs and solar energetic particles (SEPs), both of which present formidable hazards for human exploration and spacecraft operations. CRaTER characterizes the global lunar radiation environment and its biological impacts by measuring radiation behind a "human tissue-equivalent" plastic.

Serendipitously, the LRO mission made measurements during a period when GCR fluxes remained at the highest levels ever observed in the space age due to the Sun's abnormally extended quiet cycle. During this quiescent period, the diminished power, pressure, flux and magnetic flux of the solar wind allowed GCRs and SEPs to more readily interact with objects they encountered -- particularly bodies such as our Moon, which has no atmosphere to shield the blow.

"This has provided us with a unique opportunity because we've never made these types of measurements before over an extended period of time, which means we've never been able to validate our models," notes Schwadron. "Now we can put this whole modeling field on more solid footing and project GCR dose rates from the present period back through time when different interplanetary conditions prevailed." This projection will provide a clearer picture of the effects of GCRs on airless bodies through the history of the solar system.

Moreover, CRaTER's recent findings also provide further insight into radiation as a double-edge sword. That is, while cosmic radiation does pose risks to astronauts and even spacecraft, it may have been a fundamental agent of change on celestial bodies by irradiating water ice and causing chemical alterations. Specifically, the process releases oxygen atoms from water ice, which are then free to bind with carbon to form large molecules that are "prebiotic" organic molecules.

In addition to being able to accurately gauge the radiation environment of the past, the now more robust models can also be used more effectively to predict potential radiation hazards spawned by GCRs and SEPs.

Says Schwadron, "Our validated models will be able to answer the question of how hazardous the space environment is and could be during these high-energy radiation events, and the ability to do this is absolutely necessary for any manned space exploration beyond low-Earth orbit."

Indeed, current models were in agreement with radiation dose rates measured by CRaTER, which together demonstrates the accuracy of the Earth-Moon-Mars Radiation Environment Module (EMMREM) being developed at UNH. EMMREM integrates a variety of models describing radiation effects in the Earth-Moon-Mars and interplanetary space environments and has now been validated to show its suitability for real-time space weather prediction.

Media Contact: David Sims +1 (603) 862-5369 david.sims@unh.edu

See the original post:
Cosmic Rays Alter Chemistry of Lunar Ice

Cosmic rays alter chemistry of lunar ice, may create building blocks of life

ScienceDaily (Mar. 19, 2012) Space scientists from the University of New Hampshire and multi-institutional colleagues report they have quantified levels of radiation on the moon's surface from galactic cosmic ray (GCR) bombardment that over time causes chemical changes in water ice and can create complex carbon chains similar to those that help form the foundations of biological structures. In addition, the radiation process causes the lunar soil, or regolith, to darken over time, which is important in understanding the geologic history of the moon.

The scientists present their findings in a paper published online in the American Geophysical Union's Journal of Geophysical Research (JGR). The paper, titled "Lunar Radiation Environment and Space Weathering from the Cosmic Ray Telescope for the Effects of Radiation (CRaTER)," is based on measurements made by the CRaTER instrument onboard NASA's Lunar Reconnaissance Orbiter (LRO) mission. The paper's lead author is Nathan Schwadron, an associate professor of physics at the UNH Space Science Center within the Institute for the Study of Earth, Oceans, and Space (EOS). Co-author Harlan Spence is the director of EOS and lead scientist for the CRaTER instrument.

The telescope provides the fundamental measurements needed to test our understanding of the lunar radiation environment and shows that "space weathering" of the lunar surface by energetic radiation is an important agent for chemical alteration. CRaTER measures material interactions of GCRs and solar energetic particles (SEPs), both of which present formidable hazards for human exploration and spacecraft operations. CRaTER characterizes the global lunar radiation environment and its biological impacts by measuring radiation behind a "human tissue-equivalent" plastic.

Serendipitously, the LRO mission made measurements during a period when GCR fluxes remained at the highest levels ever observed in the space age due to the sun's abnormally extended quiet cycle. During this quiescent period, the diminished power, pressure, flux and magnetic flux of the solar wind allowed GCRs and SEPs to more readily interact with objects they encountered -- particularly bodies such as our moon, which has no atmosphere to shield the blow.

"This has provided us with a unique opportunity because we've never made these types of measurements before over an extended period of time, which means we've never been able to validate our models," notes Schwadron. "Now we can put this whole modeling field on more solid footing and project GCR dose rates from the present period back through time when different interplanetary conditions prevailed." This projection will provide a clearer picture of the effects of GCRs on airless bodies through the history of the solar system.

Moreover, CRaTER's recent findings also provide further insight into radiation as a double-edge sword. That is, while cosmic radiation does pose risks to astronauts and even spacecraft, it may have been a fundamental agent of change on celestial bodies by irradiating water ice and causing chemical alterations. Specifically, the process releases oxygen atoms from water ice, which are then free to bind with carbon to form large molecules that are "prebiotic" organic molecules.

In addition to being able to accurately gauge the radiation environment of the past, the now more robust models can also be used more effectively to predict potential radiation hazards spawned by GCRs and SEPs.

Says Schwadron, "Our validated models will be able to answer the question of how hazardous the space environment is and could be during these high-energy radiation events, and the ability to do this is absolutely necessary for any manned space exploration beyond low-Earth orbit."

Indeed, current models were in agreement with radiation dose rates measured by CRaTER, which together demonstrates the accuracy of the Earth-Moon-Mars Radiation Environment Module (EMMREM) being developed at UNH. EMMREM integrates a variety of models describing radiation effects in the Earth-moon-Mars and interplanetary space environments and has now been validated to show its suitability for real-time space weather prediction.

Additional co-authors on the UNH CRaTER team include Thomas Baker, Michael Golightly, Andrew Jordan, Colin Joyce, Sonya Smith, and Jody Wilson. Other co-authors are from the Aerospace Corporation, Harvard-Smithsonian Center for Astrophysics, NASA Goddard Space Flight Center, Boston University, NASA Headquarters, Scientific Data Processing, University of Tennessee, Southwest Research Institute.

Original post:
Cosmic rays alter chemistry of lunar ice, may create building blocks of life

Goal.com All-Access: Teemu Tainio says team chemistry is key to Red Bulls' success

Known for having a hardworking and relentless nature on the football pitch, New York Red Bulls midfielder Teemu Tainio is also praised for his team-first mentality.

Wanting the Red Bulls to improve from an inconsistent 2011, Tainio believes the biggest improvement that the team can make this season is off the pitch. The former Finland international believes team camaraderie can enhance New York's performance and he would like to see the players find different ways to bond.

"Maybe that's what we need to change for this year. Last year we didn't do too much together," Tainio explained to Goal.com. "Maybe this year, we'll try to go to more dinners and get together more often than last year. It always helps to build the team. "

During the preseason, Tainio noticed that with players gathering for dinners and off-the-field activities, morale was better than last season and players worked harder on the field.

Even the team's Designated Players joined in on the good times. The 32-year-old Tainio is a former Tottenham Hotspur player and leave it to a former Arsenal legend, Thierry Henry, to rub in the rivalry between the two men.

"We talk about it all the time," Tainio said. "A few weeks ago there was an Arsenal at Spurs game and we really didn't talk to each other on gameday but in a good [competitive] way. We talk about a lot of players in Europe that we've played with and know."

While the New York Red Bulls are still a work in progress, Tainio is grateful to be playing for the side. Injuries almost ended the career of player who starred for top-division clubs in Europe such as Auxierre, Sunderland and Spurs. He admits that he came close to retiring after an injury knocked him out of playing for his last European club.

Follow ALEX LABIDOU on

When Tainio received the offer by the Red Bulls, he decided to give his playing career one more chance.

"I had a chance to come here and I thought I'd give it one more shot and last year was good for me. I played 28 games," he added.

Read more from the original source:
Goal.com All-Access: Teemu Tainio says team chemistry is key to Red Bulls' success

Brain chemistry creates need for in-patient treatment

The brain chemistry of addiction is one reason its so important to offer in-patient treatment for people who seek help from chemical dependency, according to the Western Montana Mental Health Center.

The brain works on a reward system, and it becomes conditioned to substances such as opiates and alcohol, said Tammera Nauts, a licensed clinical social worker and licensed addictions counselor with the Mental Health Center. The substances end up doing for the brain what it used to do for itself, and the chemicals in the brain of an addicted person change.

A lot of addiction is the drive to avoid withdrawal, the discomfort of withdrawal, Nauts said.

So she said in-patient around the clock care is critical for people trying to break their chemical dependency. The brain is wired to seek reward, and medical professionals can help patients find other behaviors to satisfy their cravings. Not without sustained intervention is the cycle broken, she said.

Alcoholism is a disease; genetics contribute 40 percent to 50 percent of the time, and exposure contributes 50 percent to 60 percent of the time, according to the Mental Health Center.

The Missoula Recovery Center will treat people who have addiction and those who have addiction along with a mental illness.

Follow this link:
Brain chemistry creates need for in-patient treatment

Sherwood Rowland dies aged 84

F. Sherwood Rowland

Sherwood Rowland, died 10 March. © Steve Zylius / University Communications

The sad news has reached us that atmospheric chemist Sherwood Rowland died on Saturday 10 March, aged 84, from complications related to Parkinson’s disease. Best known for his discovery, along with post-doc Mario Molina, that chlorofluorocarbons (CFCs) destroy ozone nearly 40 years ago, Rowland campaigned for a ban on the use of  the widely used and lucrative CFCs.

In 1987, some years after the original discovery of the the action of CFCs, and following evidence of their work above the Antarctic to cause a hole in the ozone layer, CFCs were finally banned from sale. ‘His publicising the adverse effects of release of CFCs in the 1970s did not endear him to industry, but eventually led to his Nobel Prize, which he shared with Mario Molina and Paul Crutzen,’ said RSC President David Phillips in a statement today. ‘In the early stages of his research on CFCs, he and his students used to travel the world taking air samples – I have some photographs of him doing just that in the grounds of the Vatican in Rome in 1982 where he and I were taking part in a Discussion Meeting of the Pontifical Academy of Sciences.’

Rowland did not rest after his work on CFCs and as well as research he campaigned against other harmful air pollutants. In 2009 Rowland joined with other Nobel Prize winners to urge US President Barack Obama to increase funding for energy research and development. ‘The most important molecule involved in global warming is carbon dioxide,’ Rowland told Chemistry World at the time. ‘What we are looking for is energy solutions that are advanced and that can last for centuries or more, and chemists will need to be working on these things for an extended period of time.’

Frank Sherwood Rowland, known as Sherry, was born on June 28, 1927 in Delaware, Ohio. After gaining his PhD at the University of Chicago with physical chemist Willard Libby, Rowland originally worked as a nuclear chemist and was a founding faculty member of the University of California, Irvine campus, which was to be his home from 1964. ‘He was a major force in atmospheric chemistry, and, along with his family, he will be greatly missed by all of his colleagues too,’ Phillips said.

Rowland is survived by his wife Joan, daughter Ingrid, son Jeffrey and two grandchildren.

Laura Howes

Digg This  Reddit This  Stumble Now!  Share on Facebook  Bookmark this on Delicious  Share on LinkedIn  Bookmark this on Technorati  Post on Twitter  Google Buzz (aka. Google Reader)  

Source:
http://prospect.rsc.org/blogs/cw/?feed=rss2